EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Plasma exchange—A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction

C B Webb iD, S G Yates iD, R Sarode, J Kim iD

Transfusion · 2023-07 · 63 (7) · 1384-1390

DOI: 10.1111/trf.17448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, online erschienen am 15.06.2023. Verfasst von C B Webb und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Texas Southwestern, Dallas, Texas, USA. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Blood Component Removal, Acute Chest Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Urgent red cell exchange (RBCx) is indicated for many complications of sickle cell disease (SCD), including acute chest syndrome, stroke, and hepatic/splenic sequestration. Many who receive RBCx remain hospitalized and develop further complications, including multiple organ dysfunction syndrome (MODS), a leading cause of death in intensive care units. Therapeutic plasma exchange (TPE) has been advocated as an effective treatment of MODS, but its role in SCD compared with RBCx alone is not well studied.

Methods

We identified all ICU encounters from 2013 to 2019 involving RBCx procedures for MODS or SCD crisis that progressed to MODS, a total of 12 encounters. Data regarding hospital length of stay (LOS), survival, number of TPE procedures following RBCx, and procedure characteristics were collected. Surrogate laboratory markers of end‐organ damage and disease severity scores were recorded at the time of admission, post‐RBCx, post‐TPE, and at discharge.

Results

Eight encounters involved RBCx followed by TPE (TPE group) while four involved RBCx alone (RBCx group). The TPE group had a higher SOFA score at ICU admission (9.5 vs. 7.0), greater predicted mortality, and a statistical trend toward higher disease severity scores following RBCx relative to the RBCx group ( p = 0.10). The TPE group showed a significantly greater decrease in SOFA score between RBCx and discharge ( p = 0.04). No significant difference in mortality or hospital LOS was observed between the groups.

Conclusion

The findings suggest TPE may be considered as an adjunct treatment for patients with acute complications of SCD that progress to MODS, especially in cases where there is no significant improvement following RBCx.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellBlood Component RemovalAcute Chest SyndromeHumansPlasma ExchangeErythrocytes

Stichwörter der Autor:innen

RBC transfusiontherapeutic apheresis

Autor:innen und Institutionen

  • Department of Pathology, University of Texas Southwestern, Dallas, Texas, USA.
  • Department of Internal Medicine, University of Texas Southwestern, Dallas, Texas, USA.

ORCID-Profile: C B Webb, S G Yates, J Kim

Zitieren

APA

Webb, C. B., Yates, S. G., Sarode, R., & Kim, J. (2023). Plasma exchange—A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction. Transfusion, 63(7), 1384-1390. https://doi.org/10.1111/trf.17448

Vancouver

Webb CB, Yates SG, Sarode R, Kim J. Plasma exchange—A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction. Transfusion. 2023;63(7):1384-1390. doi:10.1111/trf.17448

BibTeX
@article{Webb2023,
  author = {Webb, C B and Yates, S G and Sarode, R and Kim, J},
  title = {Plasma exchange—A useful adjunct therapy to red cell exchange in patients with sickle cell disease and multiorgan dysfunction},
  journal = {Transfusion},
  year = {2023},
  volume = {63},
  number = {7},
  pages = {1384--1390},
  doi = {10.1111/trf.17448}
}
Kostenlos starten →